The Peptide Synthesis news column focuses entirely on technological iteration, industrial production and global trade surrounding peptide synthetic manufacturing. We regularly publish up-to-date industry information covering solid-phase synthesis, liquid-phase synthesis, biocatalytic synthesis process upgrades, high-efficiency purification technology, product yield improvement schemes and quality control optimization solutions in peptide production. Meanwhile, we track the market demand changes of GMP pharmaceutical peptides, cosmetic active peptides and laboratory research peptides, raw material price volatility, global downstream procurement tendencies, international drug administration supervision updates, export access standards and cross-border supply chain risks. In addition, we release practical content including CDMO customized synthesis project cases, OEM mass production experience, peer technical research achievements, global biotech exhibition highlights and relevant foreign trade tariff adjustments. Targeting global pharmaceutical manufacturers, scientific research institutions, cosmetic raw material factories, biochemical procurement companies and peptide distributors across the world, this column provides systematic and forward-looking industry intelligence, helping overseas clients understand the latest synthesis technology development, reasonably arrange raw material procurement and establish stable long-term cooperative relations with Chinese peptide synthesis manufacturers.
